Galecto (GLTO) | Financial Analysis & Statements
Galecto Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
0
Operating Income
-201.7M
Net Income
-200.7M
Balance Sheet Metrics
Total Assets
260.5M
Total Liabilities
20.1M
Shareholders Equity
240.4M
Debt to Equity
0.08
Cash Flow Metrics
Operating Cash Flow
-8.0M
Free Cash Flow
566.0K
Revenue & Profitability Trend
Galecto Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses | |||||
| Research & Development | 201.2M | 10.8M | 23.8M | 48.2M | 38.5M |
| Selling, General & Administrative | 9.7M | 10.5M | 12.7M | 13.0M | 13.7M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 210.9M | 21.3M | 36.5M | 61.2M | 52.2M |
| Operating Income | -210.9M | -21.3M | -36.5M | -61.2M | -52.2M |
| Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Non-Operating Items | |||||
| Interest Income | 1.2M | 844.0K | 1.7M | 722.0K | 156.0K |
| Interest Expense | - | - | - | - | - |
| Other Non-Operating Income | -84.0K | -950.0K | -3.6M | -1.1M | 319.0K |
| Pre-tax Income | -209.8M | -21.4M | -38.3M | -61.6M | -51.8M |
| Income Tax | 50.0K | 41.0K | - | - | - |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -209.8M | -21.4M | -38.3M | -61.6M | -51.8M |
| Net Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Key Metrics | |||||
| EBITDA | -210.8M | -20.2M | -32.0M | -59.6M | -52.1M |
| EPS (Basic) | - | $-18.53 | $-36.00 | $-60.75 | $-51.25 |
| EPS (Diluted) | - | $-18.53 | $-36.00 | $-60.75 | $-51.25 |
| Basic Shares Outstanding | - | 1157149 | 1062871 | 1016364 | 1010473 |
| Diluted Shares Outstanding | - | 1157149 | 1062871 | 1016364 | 1010473 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Galecto Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 257.6M | 14.2M | 21.5M | 32.8M | 62.6M |
| Short-term Investments | - | 0 | 11.7M | 27.4M | 37.6M |
| Accounts Receivable | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other Current Assets | 125.0K | 90.0K | 85.0K | 52.0K | 334.0K |
| Total Current Assets | 260.4M | 16.8M | 36.8M | 63.9M | 110.1M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 176.0K | 180.0K | 354.0K | 1.2M | 1.1M |
| Goodwill | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | 163.0K | 1.1M | 2.3M | 2.0M |
| Total Non-Current Assets | 104.0K | 293.0K | 1.5M | 9.3M | 12.1M |
| Total Assets | 260.5M | 17.1M | 38.2M | 73.2M | 122.2M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 444.0K | 377.0K | 1.7M | 3.4M | 1.5M |
| Short-term Debt | 15.0K | 12.0K | 183.0K | 476.0K | 399.0K |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.1M | 487.0K | 539.0K | 539.0K | 438.0K |
| Total Current Liabilities | 20.1M | 1.2M | 5.8M | 11.1M | 4.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 53.0K | 61.0K | 66.0K | 328.0K | 448.0K |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 28.0K | 43.0K | - | - | - |
| Total Non-Current Liabilities | 81.0K | 104.0K | 66.0K | 328.0K | 448.0K |
| Total Liabilities | 20.1M | 1.3M | 5.9M | 11.4M | 5.0M |
| Equity | |||||
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -487.4M | -277.5M | -256.1M | -217.7M | -156.1M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 240.4M | 15.8M | 32.3M | 61.8M | 117.2M |
| Key Metrics | |||||
| Total Debt | 68.0K | 73.0K | 249.0K | 804.0K | 847.0K |
| Working Capital | 240.4M | 15.6M | 30.9M | 52.8M | 105.6M |
Balance Sheet Composition
Galecto Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -209.8M | -21.4M | -38.3M | -61.6M | -51.8M |
| Depreciation & Amortization | 34.0K | 181.0K | 830.0K | 490.0K | 441.0K |
| Stock-Based Compensation | 998.0K | 3.2M | 5.4M | 5.6M | 4.5M |
| Working Capital Changes | 17.4M | -482.0K | -1.1M | 1.0M | -2.7M |
| Operating Cash Flow | -17.0M | -16.5M | -33.1M | -54.5M | -49.5M |
| Investing Activities | |||||
| Capital Expenditures | - | 0 | 83.0K | -196.0K | -223.0K |
| Acquisitions | -17.4M | - | - | - | - |
| Investment Purchases | - | 0 | -25.9M | -44.9M | -84.2M |
| Investment Sales | 0 | 11.6M | 48.2M | 57.4M | 36.4M |
| Investing Cash Flow | -17.4M | 11.6M | 22.3M | 12.4M | -48.0M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | 266.8M | 0 | 2.9M | 507.0K | 0 |
| Free Cash Flow | -6.7M | -18.6M | -36.9M | -43.1M | -52.5M |
| Net Change in Cash | 232.4M | -4.9M | -7.9M | -41.6M | -97.5M |
Cash Flow Trend
Galecto Key Financial Ratios
Valuation Ratios
Forward P/E
-30.20
Price to Book
5.71
PEG Ratio
-30.20
Profitability Ratios
Profit Margin
0.00%
Operating Margin
0.00%
Return on Equity
-109.49%
Return on Assets
-43.54%
Financial Health
Current Ratio
3.73
Debt to Equity
0.90
Beta
1.57
Per Share Data
EPS (TTM)
$-12.11
Book Value per Share
$5.02
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| GLTO | 1.5B | - | 5.71 | -109.49% | 0.00% | 0.90 |
| Vertex | 109.4B | 28.40 | 5.92 | 22.54% | 32.94% | 10.91 |
| Regeneron | 81.0B | 18.00 | 2.45 | 14.86% | 31.41% | 9.51 |
| Recursion | 1.9B | -2.44 | 1.64 | -59.54% | 4.45% | 6.89 |
| Capricor | 2.0B | -15.61 | 6.62 | -46.56% | 0.00% | 4.75 |
| Zymeworks | 2.0B | 3.79 | 7.32 | -26.72% | -76.56% | 6.80 |
Financial data is updated regularly. All figures are in the company's reporting currency.






